The development of IP was started to promote public health by bringing out authoritative and officially accepted standards for the quality of drugs including active pharmaceutical ingredients, excipients, dosage forms and medical devices for use by health professionals, patients and consumers.
• In pre-independence days,
British Pharmacopoeia was used in India.
• In 1946 Government of
India issued one list known as 'The Indian Pharmacopoeial List which was used
as a supplement to British Pharmacopoeia.
• Committee under the chairmanship
of Sir R. N. Chopra along with other nine members prepared 'The Indian
Pharmacopoeial list'.
• It was prepared by the Department
of Health, Government of India, Delhi in 1946.
• In 1948 Government of
India appointed an Indian Pharmacopoeia committee for preparing 'Pharmacopoeia
of India'.
• Tenure of this committee
was five years.
In 1955 first edition of the Indian Pharmacopoeia committee under the chairmanship of Dr. B. N. Ghosh was published.
• It is written in English
and official titles of monographs are given in Latin.
• 1960 - A supplement to
this edition was published.
In 1966 Second edition of IP was published under the chairmanship of Dr. B. Mukherji.
• Official titles of
monographs given in English.
• Doses were expressed in the
Metric system.
• Formulations of the
drugs were given immediately after the monograph of drugs.
• 1975 - A supplement to
this edition was published.
In 1985, the third edition of IP was published with
two volumes and nine appendices.
• 261 new monographs have
been added.
• Addendum I to IP was
published in 1989 where 46 new monographs were added and 126 amended.
• Addendum II was
published in 1991 where 62 new monographs were added and 110 amended.
In 1996 Fourth edition of IP was published under the
chairmanship of Dr. Nityanand.
• It has been made
effective from 1st December 1996.
• It covered 1149
monographs and 123 appendices.
• It includes 294 new
monographs and 110 monographs have been deleted.
• Addendum I has been made
effective from 31st December 2000 where 42 new monographs have been added.
• Addendum II has been
made effective from 30th June 2003 where 19 new monographs have been
added.
• The veterinary supplement to IP 1996 contains 208 monographs and four appendices.
In 2007, the fifth edition of IP was published and an addendum
to this edition was published in
2008.
• IP 2007 is presented in
three volumes.
• Volume one contains
general notices and general chapters.
• Volume two and three contains general monographs on drug substances, dosage forms and Pharmaceutical aids.
In 2010, the sixth edition of IP was published.
• The 6th edition of the
Indian Pharmacopoeia 2010 is published by the Indian Pharmacopoeia Commission (IPC),
Ghaziabad.
• This edition was
effective from 1st September, 2010. •
The Indian Pharmacopoeia 2010 is presented in three volumes.
• Volume I contains the
Notices, Preface, Structure of the IPC, Acknowledgements, Introduction, and General Chapters.
• Volume II contains the General
Notice, General Monographs on Dosage Forms and
Monographs on drug substances, dosage forms and pharmaceutical aids (A
to M).
• Volume III contains
Monographs on drug substances, dosage forms and pharmaceutical aids (N to
Z).
• Monographs on Vaccines
and Immunosera for Human use, Herbs and Herbal products, Blood and
blood-related products, Biotechnology products and Veterinary products.
• The number of monographs
of Excipients, Anticancer drugs, Herbal products and antiretroviral drugs has
been increased in this edition.
• A chapter on NMR and a chapter on microbial contamination were also updated.
In 2014, the seventh edition of Indian Pharmacopoeia
was published.
• The seventh edition of
the Indian Pharmacopoeia (IP 2014) is published by the Indian Pharmacopoeia Commission (IPC) on behalf of
the Government of India, Ministry of
Health and Family Welfare by Ghulam Nabi Azad.
• The Indian Pharmacopoeia
2014 is presented in four volumes.
• The scope of Pharmacopoeia
has been extended to include additional anticancer drugs and antiretroviral
drugs and formulations, products of biotechnology, indigenous herbs and herbal products, and veterinary
vaccines.
• The IP 2014 incorporates
2550 monographs of drugs out of which 577 are new monographs consisting of
APIs, excipients, dosage forms and herbal products etc.